Printer Friendly

Assessment of functional status of outer hair cells in Type 2 diabetes by using distortion product otoacoustic emissions.

INTRODUCTION

Otoacoustic emissions (OAEs) are low-level auditory signals produced from the outer hair cells of the cochlea. [1,2] OAEs are widely used to assess the functioning of cochlea by analyzing the outer hair cell micromechanics in humans. [3] Use of higher stimulus intensities increases OAEs and can provide useful evidence of residual hair cell activity but does not probe further deep into the auditory pathway. [4] OAEs also give an indirect idea about the functional status of inner hair cells. [5] Like any other system in the body, the auditory system also requires glucose for its complex signal processing. Exposure to hyperglycemia even for short periods will trigger the cascade of metabolic reactions, such as increasing the endothelial permeability and disturbing the cochlear endolymph electrolyte homeostasis, that will affect the cochlea both functionally and morphologically. [6] OAEs are altered if there is damage to the cochlea, but they are not disturbed if the retrocochlear neural pathway is affected. [7,8] With the sensitivity of OAEs, the audiologists may identify auditory impairment before the onset of hearing loss or before the impairment progresses further to the deeper auditory structures. [9]

Hypothesis

Type 2 diabetes alters the functional status of outer hair cells in the cochlea.

Objectives of the Study

1. To observe the effect of Type 2 diabetes on functional status of outer hair cells

2. To illustrate the effect of Type 2 diabetes on outer hair cells for right and left ear is same or different

3. To estimate the glycosylated hemoglobin (HbA1c) concentration in Type 2 diabetics and controls.

MATERIALS AND METHODS

Study Design

It is a case control study. The study was approved by the institutional ethical committee (FWA00002084 dated 16/03/2015).

Inclusion Criteria

A total of 50 Type 2 diabetic subjects of both the sex, aged between 30 to 55 years, were included in the study as cases. Age and sex matched 50 normal individuals were included as controls in the study, written informed consent was obtained from both the groups after making them to understand the objectives of the study. In test group, 32 are males and 18 are females and in the control group, 29 are males, and 21 are females.

Exclusion Criteria

Subjects were excluded from the study if they have present or past history of using ototoxic drugs, noise exposure, ear surgeries, chronic middle ear diseases, cranial trauma, metabolic disorders except for diabetes mellitus, underwent recent surgeries, any type of chronic infections, congenital hearing problems, Type 1 diabetes, smokers, and alcoholics.

Methods

HbA1c

HbA1c was estimated on the basis of latex agglutination inhibition assay using Rx imola automated analyzer. Here, the hemoglobin is hydrolyzed by the enzyme protease in the hemoglobin denaturant reagent. The reported HbA1c result is calculated as a percentage of the total hemoglobin concentration (Randox, UK). HbA1c was estimated in both the groups.

Distortion product OAEs (DPOAEs)

OAE is a conventional objective, non-invasive test protocol that assists to detect the accuracy of cochlear functioning and hearing at frequencies ranging from 1000 to 4000 Hz. From several types of OAEs, DPOAEs are used in this study.

Instrument

Biologic Scout Sport system (Natus, USA).

Recording

A probe wire that is directly connected to the instrument is placed in the patient's ear. The stimulus used includes clicks, with an intensity of 65-70 dB sound pressure level and test frequencies include 1000-4000 Hz. The results thus obtained are a numerical representation for the formula 2f1-f2 = DPOAE. Results obtained with a noise floor of more than 6 dB are noted as no response. Thus, after the compilation using the formula, the final results of the test are displayed as PASS or REFER, which in turn explain the outer hair cell functioning. PASS means normal functioning and REFER means abnormal and requires further investigation with brainstem auditory evoked potentials. In this study, if the result of OAEs is "PASS," we considered it as 1 and if the result is "REFER or FAIL" then it is considered as 2.

Statistical Analysis

Statistical analysis was conducted using MedCalc Statistical Software Version 12.7.8 (MedCalc Software bvba, Ostend, Belgium; http://www.medcalc.org; 2014), an unpaired t-test was performed to compare the mean difference between test and control group, P < 0.05 was considered as statistically significant. Odds ratio was calculated for both right and left ear OAEs.

RESULTS

HbA1c percentage among test group subjects (8.58 [+ or -] 0.83) and controls (5.28 [+ or -] 0.50) is statistically significant (<0.0001). We analyzed DPOAEs in test and control groups. The distribution of DPOAEs frequencies in test and control groups of both left and right ears was presented in Table 1. In the right ear DPOAEs, among the 50 control subjects, 38 (76%) were present and 12 (24%) were absent. Among the 50 test subjects, 16 (32%) were present, and 34 (68%) were absent. In the left ear DPOAEs, among the 50 control subjects, 41 (82%) were present and 9 (18%) were absent. Among the 50 test subjects, 13 (26%) were present and 37 (74%) were absent. In risk analysis, there was a significant increased risk was observed in both right (P [less than or equal to] 0.001; odd ratio [OR] 6.72; 95% confidence interval [CI] 2.80-16.22) and left (P [less than or equal to] 0.001; OR 12.96; 95% CI 4.97-33.80) ears.

DISCUSSION

DPOAEs were absent in the majority of people with Type 2 diabetes than in the controls. It has been observed that in left ear DPOAEs are absent more than in the right for the test group but in the controls, the opposite was established. The glycemic index is high in the test group than the controls; this indicates that diabetes has a vulnerable role on the outer hair cells function, and it may cause hearing impairment in the diabetic persons. Contrary to our findings in some studies, OAEs were not affected at most frequencies in Type 2 diabetic subjects. [10,11] The contributions of hyperglycemia, insulin resistance, and hyperlipidemia could influence outer hair cell damage or other cochlear pathologies such as stria vascularis or fibrocyte damage, as a result of metabolic alterations. [12]

Decreased amplitude of DPOAEs was reported in Type 2 diabetic patients when compared with the normal individuals. [13-19] Impaired functioning of the outer row of hair cells reduces sensitivity to the acoustic stimulus. [20-23] The possible mechanisms by which glucose is affecting the outer hair cells and resulting in abnormal OAEs are; glucose is the energy source for the cochlea if glucose is disrupted then it affects the OAEs. [12,24-26] Advanced glycosylated end products in hyperglycemia causes release of more cytokines, these affect matrix metalloproteinase and damage nerve cells, it may have some negative effect over functions of outer hair cells in diabetes. [27] Outer hair cells have ion channel which are sensitive to adenosine triphosphate (ATP) as a neurotransmitter. [28-30] When ATP and its analogs were applied to the cochlear perilymph, reductions were observed in OAE amplitudes and auditory nerve compound action potentials. [31] Functional loss of outer hair cells may result in hearing impairment. [32] Some studies also reported where hearing impairment is not associated with the hair cell dysfunctioning. [33]

CONCLUSION

Functioning of outer hair cells is altered in Type 2 diabetes. Pure tone audiometry and brainstem auditory evoked potentials will help in the deeper analysis of effects of Type 2 diabetes on hearing threshold and interpeak latencies, respectively, and these results may re-establish the findings of OAEs.

DOI: 10.5455/njppp.2016.6.0411404052016

ACKNOWLEDGMENT

Research reported in this publication was conducted by scholars at the Fogarty International Center of the NIH training program under Award Number D43 TW 009078. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.

REFERENCES

[1.] Kemp DT. Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am. 1978; 64(5):1386-91.

[2.] Lonsbury-Martin BL, McCoy MJ, Whitehead ML, Martin GK. Clinical testing of distortion-product otoacoustic emissions. Ear Hear. 1993; 14(1):11-22.

[3.] Berlin C. Hair Cell Micro-mechanics and Otoacoustic Emissions. Clifton Park, NY: Delmar Learning, Thomason Learning; 2002. P. 1-55.

[4.] Kemp DT. Otoacoustic emissions, their origin in cochlear function, and use. Br Med Bull. 2002; 63:223-41.

[5.] Rance G. Auditory neuropathy/dys-synchrony and its perceptual consequences. Trends Amplif. 2005; 9(1):1-43.

[6.] Frisina ST, Mapes F, Kim SH, Frisina DR, Frisina RD, et al. Characterization of hearing loss in aged type II diabetics. Hear Res. 2006; 211(1-2):103-13.

[7.] Cummings CW, Haughey BH, Thomas JR, Harker LA, Flint PW. Cummings Otolaryngology: Head and Neck Surgery. 4th ed. Philadelphia, PA: Mosby; 2004.

[8.] Nadol JB, Randolph GW. Clinical Handbook of Ear Nose and Throat Disorders. 5th ed. New York, NY: Informa Healthcare; 2004.

[9.] Lonsbury-Martin BL, Martin GK. Otoacoustic emissions. In: Burkard RF, Don M, Eggermont JJ, editors. Auditory Evoked Potentials: Basic Principles and Clinical Application. Baltimore: Lippincott Williams & Wilkins; 2007. p. 159-79.

[10.] Di Leo MA, Di Nardo W, Cercone S, Ciervo A, Lo Monaco M, Greco AV, et al. Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care. 1997; 20(5):824-8.

[11.] Erdem T, Ozturan O, Miman MC, Ozturk C, Karatas E. Exploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissions. Eur Arch Otorhinolaryngol. 2003; 260(2):62-6.

[12.] Hsueh W, Abel ED, Breslow JL, Maeda N, Davis RC, Fisher EA, et al. Recipes for creating animal models of diabetic cardiovascular disease. Circ Res. 2007; 100(10):1415-27.

[13.] Wang H, Zhong N. A study on DPOAE in patients with diabetes mellitus. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 1998; 12(11):483-6.

[14.] Sasso FC, Salvatore T, Tranchino G, Cozzolino D, Caruso AA, Persico M, et al. Cochlear dysfunction in type 2 diabetes: A complication independent of neuropathy and acute hyperglycemia. Metabolism. 1999; 48(11):1346-50.

[15.] Park MS, Park SW, Choi JH. Distortion product otoacoustic emissions in diabetics with normal hearing. Scand Audiol Suppl. 2001; 30(52):148-51.

[16.] Lisowska G, Namyslowski G, Morawski K, Strojek K. Cochlear dysfunction and diabetic microangiopathy. Scand Audiol Suppl. 2001; 30(52):199-203.

[17.] Aladag I, Kurt S, Eyibilen A, Guven M, Erkorkmaz U. Early evaluation of auditory dysfunction in patients with type 2 diabetes mellitus. Kulak Burun Bogaz Ihtis Derg. 2008; 18(4):203-10.

[18.] Ren J, Zhao P, Chen L, Xu A, Brown SN, Xiao X. Hearing loss in middle-aged subjects with type 2 diabetes mellitus. Arch Med Res. 2009; 40(1):18-23.

[19.] Eren E, Harman E, Arslanoglu S, Onal K. Effects of Type 2 Diabetes on Otoacoustic Emissions and the Medial Olivocochlear Reflex. Otolaryngol Head Neck Surg. 2014; 150(6):1033-1039.

[20.] Dallos P, Wang CY. Bioelectric correlates of kanamycin intoxication. Audiology. 1974; 13(4):277-89.

[21.] Harrison RV, Evans EF. Cochlear fibre responses in guinea pigs with well defined cochlear lesions. Scand Audiol Suppl. 1979; (9):83-92.

[22.] Ryan A, Dallos P. Effect of absence of cochlear outer hair cells on behavioural auditory threshold. Nature. 1975; 253(5486):44-6.

[23.] Liberman MC, Dodds LW. Single-neuron labeling and chronic cochlear pathology. III. Stereocilia damage and alterations of threshold tuning curves. Hear Res. 1984; 16(1):55-74.

[24.] Koide Y. Introductory studies on the chemical physiology of the labyrinth. Acta Med Biol. 1958; 90:1-28.

[25.] Wing KG. Studies of basic cochlear physiology and the energy-metabolism of the cochlear response in the cat. Acta Otolaryngol Suppl. 1959; 148:1-97.

[26.] Mendelsohn M, Roderique J. Cationic changes in endolymph during hypoglycemia. Laryngoscope. 1972; 82(8):1533-40.

[27.] King RH. The role of glycation in the pathogenesis of diabetic polyneuropathy. Mol Pathol. 2001; 54(6):400-8.

[28.] Bobbin RP, Thompson MH. Effects of putative transmitters on afferent cochlear transmission. Ann Otol Rhinol Laryngol. 1978; 87:185-90.

[29.] Munoz DJ, Thorne PR, Housley GD, Billett TE, Battersby JM. Extracellular adenosine 5'-triphosphate (ATP) in the endolymphatic compartment influences cochlear function. Hear Res. 1995; 90(1-2):106-18.

[30.] Munoz DJ, Thorne PR, Housley GD. P2X receptor-mediated changes in cochlear potentials arising from exogenous adenosine 5'-triphosphate in endo lymph. Hear Res. 1999; 138(1-2):56-64.

[31.] Kujawa SG, Erostegui C, Fallon M, Crist J, Bobbin RP. Effects of adenosine 5'-triphosphate and related agonists on cochlear function. Hear Res. 1994; 76(1-2):87-100.

[32.] Orts Alborch M, Morant Ventura A, Garcia Callejo J, Perez del Valle B, Lorente R, Marco Algarra J. The study of otoacoustic emissions in diabetes mellitus. Acta Otorrinolaringol Esp. 1998; 49:25(1)-8.

[33.] Nageris B, Hadar T, Feinmesser M, Elidan J. Cochlear histopathologic analysis in diabetic rats. Am J Otol. 1998; 19(1):63-5.

Source of Support: Nil, Conflict of Interest: None declared.

Rajesh Paluru (1), Yoganandareddy Indla (2), Ramaswamy Chellam (3), Rajani Santhakumari (4)

(1) Department of Physiology, Saveetha University, Chennai, Tamil Nadu, India, (2) Department of Physiology, SVS Medical College, Mahaboobnagar, Telangana, India, (3) Department of Physiology, Saveetha Medical College, Chennai, Tamil Nadu, India, (4) Department of Physiology, Mediciti Institute of Medical Sciences, Ghanpur, Telangana, India

Correspondence to: Rajesh Paluru, E-mail: drrajeshpaluru@gmail.com

Received: April 21, 2016; Accepted: May 04, 2016
Table 1: Odds ratio of both right and left ears DPOAEs

Results      Controls    Test        OR (95% CI)          P value
             (%)         (%)

Right ear
Pass         38 (76.0)   16 (32.0)       Reference        <0.001
Fail/refer   12 (24.0)   34 (68.0)   6.72 (2.80-16.22)

Left ear
Pass         41 (82.0)   13 (26.0)       Reference        <0.001
Fail/refer   9 (18.0)    37 (74.0)   12.96 (4.97-33.80)

P<0.05 is consider significant. DPOAEs: Distortion product
otoacoustic emissions, OR: Odd ratio, CI: Confidence interval
COPYRIGHT 2016 Association of Physiologists, Pharmacists and Pharmacologists
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:RESEARCH ARTICLE
Author:Paluru, Rajesh; Indla, Yoganandareddy; Chellam, Ramaswamy; Santhakumari, Rajani
Publication:National Journal of Physiology, Pharmacy and Pharmacology
Article Type:Report
Date:Sep 1, 2016
Words:2282
Previous Article:Synergetic effect of Probiotic and Nigella sativa to control enteric and respiratory infections in an animal model.
Next Article:Heart rate variability is reduced in sedentary young females with higher body mass index.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters